Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica

Dario Camellino1, Francesco Paparo2, Silvia D Morbelli3

  • 1Division of Rheumatology, La Colletta Hospital, Azienda Sanitaria Locale 3, Arenzano, and Autoimmunology Laboratory, Department of Internal Medicine, University of Genova, Italy.

Abstract

Insights

Fluorodeoxyglucose-positron emission tomography (FDG-PET) reveals typical joint uptake in polymyalgia rheumatica (PMR) patients. Imaging is crucial for detecting large-vessel vasculitis (LVV) as clinical factors do not predict its presence.

Area of Science:

  • Nuclear medicine
  • Rheumatology
  • Vascular imaging

Background:

  • Polymyalgia rheumatica (PMR) is an inflammatory condition affecting joints and potentially large vessels.
  • Distinguishing PMR with large-vessel vasculitis (LVV) from PMR without LVV can be challenging using clinical assessments alone.

Purpose of the Study:

  • To evaluate joint and vessel uptake in PMR patients using FDG-PET/CT.
  • To correlate FDG-PET/CT findings with clinical and laboratory data.
  • To determine the utility of FDG-PET/CT in identifying LVV in PMR patients.

Main Methods:

  • A standardized clinical examination and FDG-PET/CT were performed on consecutive PMR patients and controls.
  • Uptake was assessed using a qualitative visual score and semi-quantitative methods (SUV, TBR).
  • Patients were categorized based on clinical presentation and FDG-PET/CT findings, including the presence of LVV.

Main Results:

  • PMR patients demonstrated higher articular uptake compared to controls.
  • Vascular uptake was increased in PMR patients across most arterial territories, particularly when assessed visually.
  • Fifty percent of PMR patients showed PET evidence of LVV (uptake ≥ liver uptake).
  • Clinical and laboratory findings showed a weak correlation with FDG-PET/CT uptake and could not predict LVV.

Conclusions:

  • FDG-PET/CT shows a characteristic joint uptake pattern in PMR.
  • LVV is frequently present in PMR patients, often undetected by clinical evaluation.
  • FDG-PET/CT is a valuable imaging tool for assessing LVV in PMR, as clinical and laboratory predictors are lacking.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
197
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
87
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
113
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
240
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.5K